课题基金 / 基金详情

BI-WEEKLY DOSING REGIMENS OF IDURONATE-2-SULFATASE ENZYME REPLACEMENT MPS II

BI-WEEKLY DOSING REGIMENS OF IDURONATE-2-SULFATASE ENZYME REPLACEMENT MPS II
艾杜糖酸-2-硫酸酯酶替代品 MPS II 每两周一次的给药方案
批准号：
7377468
负责人：
JOSEPH J. MUENZER
金额：
$1.39万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
项目状态：
已结题
起止时间：
2005-12-01 至 2006-11-30
来源：
https://reporter.nih.gov/project-details/7377468
关键词：
BIWEEKLYDOSINGREGIMENSIDURONATE

项目摘要

项目成果

JOSEPH J. MUENZER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is designed to further investigate the effectiveness and safety of this nex experimental treatment for Hunter Syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TKT024EXT: MPS II PATIENTS RECEIVING IDURONATE-2-SULFATASE ENZYME REPLACEMENT
CLINICAL TRIAL: MAINTENANCE STUDY OF IDURONATE-2-SULFATASE REPLACEMENT THERAPY I
MAINTENANCE STUDY OF IDURONATE-2-SULFATASE REPLACEMENT THERAPY IN MPS II PATIENT
TKT024EXT: MPS II PATIENTS RECEIVING IDURONATE-2-SULFATASE ENZYME REPLACEMENT
海外基金